Do you want to read an article? Please log in or register.
Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Non-Erosive Reflux Disease
Gastroesophageal Reflux Disease (GERD)
Related content
Esophagus DiseasesGastroesophageal Reflux Disease (GERD)
VALIDATION OF ESOPHAGEAL GLOBAL SYMPTOM SEVERITY AS A PATIENT REPORTED OUTCOME FOR EVALUATION OF REFLUX SYMPTOMS
Am J Gastroenterol
Chan WW, Schroeder M, Richardson A, Shah N, Muftah M, Muftah S, Siboni S, Sozzi M, Wong MW, Chen CL, Gyawali CP, Milan Score Working Group
doi: 10.14309/ajg.0000000000003499
Inflammatory Bowel Disease
Disease-State Dependent Associations Between Intrinsic Brain Function and Symptoms of Fatigue, Depression, and Anxiety in Crohn's Disease
Inflamm Bowel Dis
Thomann AK, Schmitgen MM, Stephan JC, Knoedler LL, Gass A, Thomann PA, Ebert MP, Reindl W, Wolf RC
doi: 10.1093/ibd/izae318
RECOMMENDED
Celiac Disease
Gastrointestinal and Extraintestinal Symptoms among Celiac Disease Patients Undergoing a Dose Specified Gluten Challenge: a Systematic Review and Meta-Analysis
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Banegas M, Marin DF, Naskar N, Correa TL, Rotman C, Regis S, Simpson A, Chang D, Silvester J, Therrien A
doi: 10.14309/ajg.0000000000003506
Esophagus Diseases
Histologic response is associated with improved esophageal distensibility and symptom burden in pediatric eosinophilic esophagitis
Gastroenterology
Kennedy K, Burger C, Pan Z, Umeweni CN, Alston M, Benitez A, Furuta GT, Mahon M, Ruffner MA, Quinn L, Muir A, Menard-Katcher C
doi: 10.1053/j.gastro.2025.07.042
Inflammatory Bowel Disease
Improvement in Serum Eosinophilia is Observed in Clinical Responders to Ustekinumab but not Adalimumab in Inflammatory Bowel Disease
J Crohns Colitis
Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N
doi: 10.1093/ecco-jcc/jjaf006
Inflammatory Bowel Disease
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study
Am J Gastroenterol
Lee SD, Vermeire S, Ungaro R, Vadhariya A, Durand F, Morris N, Yu G, Fisher DA, Traxler K, Long M
doi: 10.14309/ajg.0000000000003410
Inflammatory Bowel Disease
Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients with Inflammatory Bowel Disease
Am J Gastroenterol
Hong SJ, Dalal RS, Kuhn KA, Stahly A, Scott F, Click B, Way A, Malik F, Davis JM 3rd, Shmais M, Raffals L, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland J, Patel S, Weisman MH, Ermann J, Jan R
doi: 10.14309/ajg.0000000000003292
ColonoscopyInflammatory Bowel Disease
Diagnostic Accuracy of Non-Invasive Biomarkers and Imaging for Evaluating Postoperative Recurrence in Crohn's Disease
Clin Gastroenterol Hepatol
Samnani S, Ray CM, Gill P, Stein L, Buhler KA, Leong RW, Smith RL, De Cruz P, Kaplan GG, Seow CH, Lu C, Guizzetti L, Hoentjen F, Marshall JK, Singh S, Panaccione R, Novak KL, Ma C
doi: 10.1016/j.cgh.2025.03.030
Inflammatory Bowel Disease
Non-colorectal Cancer Screening and Vaccinations in Patients with Inflammatory Bowel Disease: Expert Review
Clin Gastroenterol Hepatol
Caldera F, Kane S, Long M, Hashash JG
doi: 10.1016/j.cgh.2024.12.011